2025 Journal Article Pharmacogenomic curriculum in Australian medical schools: a content analysis studyThomas, Jade, Yong, Faith R., Kryzyaniak, Natalia, Noble, Christy and Freeman, Christopher R. (2025). Pharmacogenomic curriculum in Australian medical schools: a content analysis study. Pharmacogenomics, ahead-of-print (ahead-of-print), 1-9. doi: 10.1080/14622416.2025.2452834 |
2024 Journal Article Benchmarking hospital clinical pharmacy practice using standardised key performance indicators (KPIs)Cossart, Amelia R., Canning, Martin L., Yong, Faith R. and Freeman, Christopher R. (2024). Benchmarking hospital clinical pharmacy practice using standardised key performance indicators (KPIs). Journal of Pharmaceutical Policy and Practice, 17 (1) 2431181, 1-18. doi: 10.1080/20523211.2024.2431181 |
2024 Journal Article How do residential aged care antibiograms compare with other local resistance data?Khatri, Dipti, Falconer, Nazanin, Coulter, Sonali, Gray, Leonard C., Paterson, David L. and Freeman, Christopher (2024). How do residential aged care antibiograms compare with other local resistance data?. American Journal of Infection Control. doi: 10.1016/j.ajic.2024.12.001 |
2024 Conference Publication Chemical restraint in acute care. A consensus driven definition for standardised reporting.Hillen, Jodie, Canning, Martin, Ailabouni, Nagham and Freeman, Chris (2024). Chemical restraint in acute care. A consensus driven definition for standardised reporting.. Medicines Management 2024, Adelaide, SA, Australia, 14-16 November 2024. |
2024 Conference Publication Intravenous iron staining – evaluation of a 7-year quality improvement project to mitigate a preventable adverse effectCanning, Martin, Hillen, Jodie, Kashiwagi, Maya, Alizadeh, Negin and Freeman, Chris (2024). Intravenous iron staining – evaluation of a 7-year quality improvement project to mitigate a preventable adverse effect. International Forum on Quality and Safety in Healthcare, Brisbane, QLD, Australia, 6-8 November 2024. |
2024 Journal Article Consumer perceptions of direct-to-consumer electronic prescription services in Queensland, AustraliaCossart, Amelia R., Kennedy, Eloise, Yong, Faith R., Hillen, Jodie B. and Freeman, Christopher R. (2024). Consumer perceptions of direct-to-consumer electronic prescription services in Queensland, Australia. Digital Health, 10, 20552076241294184-10. doi: 10.1177/20552076241294184 |
2024 Other Outputs Defining and evaluating chemical restraint use in Metro North HealthFreeman, Chris, Canning, Martin, Ailabouni, Nagham, Hillen, Jodie, Alker, Hunter, Hart, Grace and Soen, Dicky (2024). Defining and evaluating chemical restraint use in Metro North Health. Brisbane, QLD, Australia: The University of Queensland. |
2024 Journal Article Intravenous iron staining. Real-world incidence, preventability, and mitigation tools from a long-term quality improvement projectCanning, Ml, Hillen, Jb, Kashiwagi, M, Alizadeh, N and Freeman, Cr (2024). Intravenous iron staining. Real-world incidence, preventability, and mitigation tools from a long-term quality improvement project. International Journal for Quality in Health Care, 36 (4) mzae096. doi: 10.1093/intqhc/mzae096 |
2024 Journal Article Antibiogram development for Australian residential aged care facilitiesKhatri, Dipti, Falconer, Nazanin, Coulter, Sonali, Gray, Leonard C., Paterson, David L. and Freeman, Christopher (2024). Antibiogram development for Australian residential aged care facilities. Infection Control & Hospital Epidemiology, 45 (11), 1-7. doi: 10.1017/ice.2024.120 |
2024 Conference Publication Intravenous iron staining – evaluation of a 7-year quality improvement projectCanning, Martin, Hillen, Jodie, Kashiwagi, Maya, Alizadeh, Negin and Freeman, Chris (2024). Intravenous iron staining – evaluation of a 7-year quality improvement project. Herston Health Precinct 2024, Brisbane, QLD Australia, September 2024. |
2024 Conference Publication Patient and carer experiences using a telepharmacy serviceBarwick, Anna, Freeman, Christopher, Caffery, Liam and Smith, Anthony (2024). Patient and carer experiences using a telepharmacy service. PSA24, Sydney, Australia, 2-5 August 2024. |
2024 Journal Article Exploring stakeholders’ perspectives on antibiogram use, development, and implementation in residential aged care settingsKhatri, Dipti, Falconer, Nazanin, de Camargo Catapan, Soraia, Coulter, Sonali, Gray, Leonard C., Paterson, David L. and Freeman, Christopher (2024). Exploring stakeholders’ perspectives on antibiogram use, development, and implementation in residential aged care settings. Research in Social and Administrative Pharmacy, 20 (8), 747-754. doi: 10.1016/j.sapharm.2024.04.011 |
2024 Journal Article RSAP annual best paper awardShiyanbola, Olayinka, Freeman, Christopher, Houle, Sherilyn, Lima, Tacio and Melton, Brittany (2024). RSAP annual best paper award. Research in Social and Administrative Pharmacy, 20 (3). doi: 10.1016/S1551-7411(24)00038-X |
2024 Journal Article Understanding Australian pharmacy degree holders’ job preferences through the lens of motivation-hygiene theoryThai, Thao, Lancsar, Emily, Spinks, Jean, Freeman, Christopher and Chen, Gang (2024). Understanding Australian pharmacy degree holders’ job preferences through the lens of motivation-hygiene theory. Social Science & Medicine, 348 116832, 116832. doi: 10.1016/j.socscimed.2024.116832 |
2024 Other Outputs Indications for Pharmacogenomic Testing in AustraliaSuthers, Graeme, Stocker, Sophie, Somogyi, Andrew, Freeman, Chris, Day, Richard, Polasek, Tom, Hughes, Stephen, Kirkpatrick, Carl, Mostafa, Sam, Minck, Sandy, Nguyen, Lan, Hesson, Luke, White, Vanessa and Nandakumar, Rajuel (2024). Indications for Pharmacogenomic Testing in Australia. Sydney: The Royal College of Pathologists of Australasia. |
2024 Other Outputs Intravenous iron staining: evaluation of a 7-year quality improvement project to mitigate a preventable adverse drug eventFreeman, Chris, Canning, Martin, Kashiwagi, Maya, Alizadeh, Negin and Hillen, Jodie (2024). Intravenous iron staining: evaluation of a 7-year quality improvement project to mitigate a preventable adverse drug event. Brisbane, QLD, Australia: The University of Queensland. |
2024 Journal Article Partnering with a stakeholder steering group to co‐design the PRIME deprescribing conversation tool: reflections and recommendationsAilabouni, Nagham J., Weir, Kristie Rebecca, Brandt, Nicole, Hanjani, Leila Shafiee, Green, Ariel, Thompson, Wade, Freeman, Christopher R., Mangin, Dee, Bohill, Ruth, Furst, Chloe and Reeve, Emily (2024). Partnering with a stakeholder steering group to co‐design the PRIME deprescribing conversation tool: reflections and recommendations. Basic and Clinical Pharmacology and Toxicology, 134 (1), 121-125. doi: 10.1111/bcpt.13938 |
2024 Journal Article Clinical impact of antibiograms as an intervention to optimise antimicrobial prescribing and patient outcomes – a systematic reviewKhatri, Dipti, Freeman, Christopher, Falconer, Nazanin, Catapan, Soraia De Camargo, Gray, Len and Paterson, David L. (2024). Clinical impact of antibiograms as an intervention to optimise antimicrobial prescribing and patient outcomes – a systematic review. American Journal of Infection Control, 52 (1), 107-122. doi: 10.1016/j.ajic.2023.08.013 |
2024 Journal Article Clinical utility and reimbursement of next-generation sequencing-based testing for myeloid malignanciesSoderquist, Craig R., Freeman, Christopher, Lin, Wen-Hsuan, Leeman-Neill, Rebecca J., Gu, Yue, Carter, Melissa C., Stutzel, Kate C., Sigcha, Evelyn, Alobeid, Bachir, Fernandes, Helen, Bhagat, Govind, Mansukhani, Mahesh M. and Hsiao, Susan J. (2024). Clinical utility and reimbursement of next-generation sequencing-based testing for myeloid malignancies. Journal of Molecular Diagnostics, 26 (1), 5-16. doi: 10.1016/j.jmoldx.2023.09.012 |
2023 Journal Article A scoping review of health system guidelines for pharmacist responsibilities when dispensing opioidsOlsen, William, Freeman, Chris, Adewumi, Adeleke and La Caze, Adam (2023). A scoping review of health system guidelines for pharmacist responsibilities when dispensing opioids. Exploratory Research in Clinical and Social Pharmacy, 12 100382, 100382. doi: 10.1016/j.rcsop.2023.100382 |